| Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor and tissue-type PA messenger RNAs in human hepatocellular carcinoma G De Petro, D Tavian, A Copeta, N Portolani, ... Cancer Reaserch, 2234-2239, 1998 | 138 | 1998 |
| u‐PA and c‐MET mRNA expression is co‐ordinately enhanced while hepatocyte growth factor mRNA is down‐regulated in human hepatocellular carcinoma D Tavian, G De Petro, A Benetti, N Portolani, SM Giulini, S Barlati International journal of cancer 87 (5), 644-649, 2000 | 137 | 2000 |
| Neutral lipid storage diseases as cellular model to study lipid droplet function S Missaglia, RA Coleman, A Mordente, D Tavian Cells 8 (2), 187, 2019 | 72 | 2019 |
| RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma D Tavian, G De Petro, M Colombi, N Portolani, SM Giulini, R Gardella, ... International Journal of Cancer, 1994 | 65 | 1994 |
| Recent insights into genotype–phenotype relationships in patients with Rett syndrome using a fine grain scale RA Fabio, B Colombo, S Russo, F Cogliati, M Masciadri, S Foglia, ... Research in Developmental Disabilities 35 (11), 2976-2986, 2014 | 63 | 2014 |
| Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function D Tavian, S Missaglia, C Redaelli, EM Pennisi, G Invernici, ... Human molecular genetics 21 (24), 5318-5328, 2012 | 61 | 2012 |
| Topoisomerases and anthracyclines: recent advances and perspectives in anticancer therapy and prevention of cardiotoxicity A Mordente, E Meucci, G EttoreMartorana, D Tavian, A Silvestrini Current medicinal chemistry 24 (15), 1607-1626, 2017 | 60 | 2017 |
| Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene C Redaelli, RA Coleman, L Moro, C Dacou-Voutetakis, SM Elsayed, ... Orphanet Journal of Rare Diseases 5, 1-11, 2010 | 56 | 2010 |
| Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients EM Pennisi, M Arca, E Bertini, C Bruno, D Cassandrini, A D’amico, ... Orphanet journal of rare diseases 12, 1-10, 2017 | 54 | 2017 |
| Early exposure to alcohol leads to permanent impairment of dendritic excitability in neocortical pyramidal neurons A Granato, LM Palmer, A De Giorgio, D Tavian, ME Larkum Journal of Neuroscience 32 (4), 1377-1382, 2012 | 54 | 2012 |
| Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients L Mandelli, M Mazza, G Martinotti, M Di Nicola, D Tavian, E Colombo, ... Journal of affective disorders 119 (1-3), 205-209, 2009 | 53 | 2009 |
| Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit … K Hirano, T Tanaka, Y Ikeda, S Yamaguchi, N Zaima, K Kobayashi, ... Biochemical and biophysical research communications 443 (2), 574-579, 2014 | 49 | 2014 |
| Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability AG Manente, G Pinton, D Tavian, G Lopez-Rodas, E Brunelli, L Moro PloS one 6 (10), e25676, 2011 | 46 | 2011 |
| Social stress regulation in 4-month-old infants: contribution of maternal social engagement and infants'5-HTTLPR genotype R Montirosso, L Provenzi, D Tavian, F Morandi, A Bonanomi, S Missaglia, ... Early human development 91 (3), 173-179, 2015 | 44 | 2015 |
| Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings S Missaglia, E Tasca, C Angelini, L Moro, D Tavian Molecular Genetics and Metabolism 115 (2-3), 110-117, 2015 | 43 | 2015 |
| Nanotechnology advances in brain tumors: the state of the art G Invernici, S Cristini, G Alessandri, S E Navone, L Canzi, D Tavian, ... Recent patents on anti-cancer drug discovery 6 (1), 58-69, 2011 | 41 | 2011 |
| Improved cytochemical method for detecting Jordans’ bodies in neutral lipid storage diseases D Tavian, R Colombo Journal of clinical pathology 60 (8), 956-958, 2007 | 39 | 2007 |
| A myopathy with unusual features caused by PNPLA2 gene mutations EM Pennisi, S Missaglia, S Dimauro, C Bernardi, HO Akman, D Tavian Muscle & Nerve 51 (4), 609-613, 2015 | 36 | 2015 |
| Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide M Colombi, N Zoppi, G De Petro, E Marchina, R Gardella, D Tavian, ... Journal of Biological Chemistry 278 (16), 14346-14355, 2003 | 36 | 2003 |
| Metabolic lipid muscle disorders: biomarkers and treatment C Angelini, E Pennisi, S Missaglia, D Tavian Therapeutic Advances in Neurological Disorders 12, 1756286419843359, 2019 | 34 | 2019 |
